Trial intelligence / Profile preview

fMRI of ATP-sensitive Cough Pathways in Chronic Cough

NCT03722849Completed

Start
Mar 2019
Primary completion
May 2022
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of adenosine 5'-triphosphate in cough (2 arms). Primary endpoints: Brainstem Neural Activations to Capsaicin and Brainstem Neural Activations to ATP. Started Mar 2019; status: completed.

02

Drugs

adenosine 5'-triphosphate
03

Conditions

cough

Beyond the preview

Go deeper on NCT03722849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03722849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call